Contact this trialFirst, we need to learn more about you.
Alpha-1 Adrenergic Receptor Antagonist
Doxazosin Mesylate, Extended Release +1 More for Post-Traumatic Stress Disorder
Recruiting2 awardsPhase 2
San Francisco, California
This trial will assess doxazosin's effectiveness for treating nightmares, sleep quality, and other PTSD symptoms in adult male and female veterans with PTSD.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service